Literature DB >> 2079996

Alpha-1-antichymotrypsin in renal biopsies.

P Conz1, P A Bevilacqua, C Ronco, M Feriani, A Brendolan, R Dell'Aquila, G Pietribiasi, S Meli, G La Greca.   

Abstract

Alpha 1-Antichymotrypsin (alpha 1-AK) and alpha-1-antitrypsin (alpha 1-AT) represent a defense mechanism to protect the tissues from proteolytic enzyme activity. We studied the implication of alpha 1-AK and alpha 1-AT in glomeruli of patients with different nephropathies based on the analysis of 52 paraffin-embedded renal biopsies with alpha 1-AK and alpha 1-AT antisera. The results demonstrate an intense alpha 1-AK glomerular staining in renal biopsies from patients with minimal-change disease, while a minor staining of this protein was found in the other nephropathies. No significant evidence of alpha 1-AT deposits was observed in our cases. Our findings suggest that when alpha 1-AK is lacking in glomeruli the defense mechanisms against proteolytic enzymes may not be efficient enough to protect the glomerular structures and limit the damage. Since alpha 1-AK is a reactant of the acute phase of inflammation, it may be considered as a marker of activity for monocyte-macrophages in glomerular damage.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2079996     DOI: 10.1159/000186180

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  2 in total

1.  Urinary haptoglobin, alpha-1 anti-chymotrypsin and retinol binding protein identified by proteomics as potential biomarkers for lupus nephritis.

Authors:  A Aggarwal; R Gupta; V S Negi; L Rajasekhar; R Misra; P Singh; V Chaturvedi; S Sinha
Journal:  Clin Exp Immunol       Date:  2017-02-23       Impact factor: 4.330

2.  SerpinA3 in the Early Recognition of Acute Kidney Injury to Chronic Kidney Disease (CKD) transition in the rat and its Potentiality in the Recognition of Patients with CKD.

Authors:  Andrea Sánchez-Navarro; Juan M Mejía-Vilet; Rosalba Pérez-Villalva; Diego L Carrillo-Pérez; Brenda Marquina-Castillo; Gerardo Gamba; Norma A Bobadilla
Journal:  Sci Rep       Date:  2019-07-17       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.